Jim Cramer Says Stryker (SYK) and Its Orthopedic Peers Are Facing a Real Tough Run

Jim Cramer Says Stryker (SYK) and Its Orthopedic Peers Are Facing a Real Tough Run Syeda Seirut Javed Sun, June 21, 2026 at 7:42 PM GMT+2 2 min read SYK JNJ Stryker Corporation (NYSE: SYK ) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been . Toward the end of the lightning round, a caller asked if the stock is a buy, sell, or hold. In response, Cramer said: See, I kept thinking that there would be a consolidator and Stryker would do the consolidating and J&J’s spinning off its orthopedics, too.

And it has not come true… And I’m kind of bummed because I thought that that group, which was Zimmer, Biomet, and Stryker, I thought they would work out something, and they haven’t, and it’s been a real tough run. A stock market graph. Photo by energepic.

com Stryker Corporation (NYSE:SYK) supplies medical technologies, including surgical equipment, joint replacement implants, robotic applications, and AI-assisted virtual care platforms. During the episode aired on May 23, 2025, a caller asked about the stock, and Cramer responded: I like Stryker, but you know, I don’t like it enough. I don’t like it as much as if it was Intuitive Surgical.

That’s the one that I thought we should buy. ISRG. It is worth noting that since the above comment was aired, Stryker Corporation’s (NYSE:SYK) stock has declined by around 17%.

While we acknowledge the potential of SYK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock . READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years   Disclosure: None.

Follow Insider Monkey on Google News .